Name: Better Breathing Week 2022
Start: 24/01/2022 12:30 PM +00:00
End: 06/05/2022 03:59 AM +00:00

Access your certificate of attendance here. Download the certificate, fill it out with your information and save a copy for your records.

Certificates

AstraZeneca is a global, innovation-driven biopharmaceutical business with a focus on the discovery, development and commercialization of primary and specialty care medicines that transform lives. Our primary focus is on three important areas of healthcare: Cardiovascular, Renal and Metabolic disease; Oncology; and Respiratory &amp; Immunology. AstraZeneca operates in more than 100 countries and its innovative medicines are used by millions of patients worldwide. In Canada, we employ roughly 950 employees across the country and our headquarters are located in Mississauga, Ontario. The company invested $145 million in Canadian research and development in 2019 and is designated a Global Clinical Trial Delivery site &ndash; leading the delivery of more than 60 global clinical trials in oncology and respiratory disease. For more information, please visit the company&rsquo;s website at www.astrazeneca.ca

AstraZeneca Canada

At Bristol Myers Squibb, we work every day to help patients. &nbsp;Patients are at the center of everything we do. &nbsp;They inspire us. &nbsp;They are the reason we come to work each day. &nbsp;We aspire to be at the center of a vibrant healthcare ecosystem, where academic research centers, biotech and biopharma companies all contribute to continued scientific advancement.
Chez Bristol Myers Squibb, nous travaillons chaque jour pour aider les patients. &nbsp;Les patients sont au c&oelig;ur de tout ce que nous faisons. Ils nous inspirent et c&rsquo;est pour eux que nous venons travailler tous les jours. &nbsp;Nous aspirons &agrave; &ecirc;tre au centre d&rsquo;un &eacute;cosyst&egrave;me de soins de sant&eacute; dynamique, dans lequel les centres de recherche universitaires, ainsi que les soci&eacute;t&eacute;s biotechnologiques et biopharmaceutiques contribuent aux avanc&eacute;es scientifiques continues.

Bristol-Myers Squibb Canada

ProResp is committed to one purpose: Helping People Breathe right at home! Our respiratory therapists provide expert and compassionate care to help improve quality of life and maximize independence. We do this by building and nurturing relationships of trust with patients, caregivers, and community healthcare partners. Now in our 41st year of bringing the respiratory therapist to the community, we continue our innovation through virtual care. Aetonix&rsquo;s aTouchAway will put your patients at the centre of their care, surrounded by their healthcare team and family caregivers, all interconnected by an app that provides so much more than remote monitoring. aTouchAway also:&nbsp;
<ul>
<li>Enables sharing of healthcare data amongst team members</li>
<li>Provides workflows and education resources to patients and caregivers;</li>
<li>Facilitates digital communication within the circle of care.</li>
</ul>
Virtual care has proven to be a valuable tool in safely managing patients during the pandemic. ProResp combines virtual care with a blend of in-person care that is second to none &ndash; experience the ProResp difference yourself. We never stopped caring and we never will! We are just aTouchAway.

ProResp

&nbsp;
Viatris empowers people worldwide to live healthier at every stage of life.
VIATRIS&trade; is a new kind of global healthcare company formed in 2020 through the combination of Mylan and Upjohn, formerly a division of Pfizer. By integrating the strengths of these two companies, including our global workforce of approximately 45,000, we aim to deliver increased access to affordable, quality medicines for patients worldwide, regardless of geography or circumstance.
Our portfolio in Canada comprises more than 100 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized iconic brands, generic, complex generic medicines, and a growing portfolio of biosimilars.
Because of our unwavering belief that better access leads to better health, we leverage our best-in-class manufacturing and proven commercial capabilities to bring quality medicines to patients when and where they need them. Viatris offers a robust portfolio focusing on key priority therapeutic areas including respiratory, cardiovascular, psychiatry, urology, neurology and pain, oncology, diabetes, cystic fibrosis and more.
<a href="https://www.viatris.com/en-ca/lm/Canada" target="_blank" rel="noopener">Visit our website.&nbsp;</a>
<a href="https://www.wixela.ca" target="_blank" rel="noopener">Visit the Wixela Inhub site</a>
&nbsp;
&nbsp;

Viatris

Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. As a leading medical technology company, Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications enhance the company&rsquo;s foundation in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care.&nbsp;
A leader in Point of Care solutions, Siemens Healthineers offers a product portfolio that provides you with immediate, convenient, and easy-to-use diagnostic testing at the patient bedside. From the Emergency Department to the physician&rsquo;s office, clinical management decisions can be made immediately, resulting in improved patient safety, better clinical outcomes, and increased patient satisfaction.&nbsp;
In fiscal 2021, which ended on September 30, 2021, Siemens Healthineers, which has approximately 66,000 employees worldwide, generated revenue of &euro;18.0 billion and adjusted EBIT of &euro;3.1 billion. Further information is available at <a href="http://www.siemens-healthineers.com" target="_blank" rel="noopener">www.siemens-healthineers.com</a>.

Siemens Healthineers

Janssen Inc., a pharmaceutical company of Johnson &amp; Johnson, has been an innovator in the Canadian healthcare industry for over 50 years. We are guided by Our Credo, where our first responsibility is to the doctors, nurses and patients, and mothers and fathers, and all others who use our products and services. Our ultimate goal is to help people live healthy lives.

Janssen Inc.

&nbsp;
GSK is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. For further information, please visit www.ca.gsk.com.
GSK est une entreprise du secteur des sciences de la vie d&rsquo;envergure mondiale qui a pour mission d&rsquo;am&eacute;liorer la qualit&eacute; de vie en aidant les gens &agrave; &ecirc;tre plus actifs, &agrave; se sentir mieux et &agrave; vivre plus longtemps. Pour obtenir de plus amples renseignements, veuillez visiter le site www.ca.gsk.com.

Sanofi Genzyme Canada
As the specialty care global business unit of Sanofi, our work is focused in the areas of immunology, rare diseases, rare blood disorders, multiple sclerosis, and oncology. Each day we continue to advance new therapies, demonstrating our commitment to making a positive impact on the lives of patients around the world. For more information, visit Sanofi.ca or follow us on Twitter @SanofiCanada.
&nbsp;

Sanofi Genzyme Canada

Boehringer Ingelheim Canada, Ltd

For more than 125 years, Merck, known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world&rsquo;s most challenging diseases in pursuit of our mission to save and improve lives. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships.&nbsp;
Today, Merck continues to be at the forefront of research to prevent and treat diseases that threaten people and animals &ndash; including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases &ndash; as we aspire to be the premier research-intensive biopharmaceutical company in the world. For more information about our operations in Canada, visit www.merck.ca and connect with us on YouTube and Twitter @MerckCanada.

Merck Canada Inc. (Lung Cancer)

Merck Canada Inc. (COVID-19)

Merck Canada (Chronic Cough)

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are focused on developing life-changing medicines for people with serious diseases &mdash; often with limited or no options &mdash; so they can live their lives more fully. By transforming biopharmaceutical discoveries into novel medicines, we are working to give people around the world the opportunity to redefine what&rsquo;s possible &ndash; to make the &ldquo;small wins&rdquo; big again.
We are a fully integrated, growing, biopharmaceutical company with a diverse portfolio of marketed medicines and novel product candidates in two key therapeutic areas: neuroscience and oncology. We are an industry leader in sleep disorders and epilepsy and are growing our presence in oncology including hematologic malignancies and solid tumors.&nbsp;
Across our commercial franchises and development programs, we focus on innovative therapies and support for adults and children living with these conditions. We actively explore new options for patients including novel compounds, small molecules and biologics, and through cannabinoid science and innovative delivery technologies.

Jazz Pharmaceuticals Canada, Inc.

Seqirus - On the Front Line
Derived from the expression 'securing health for all of us', Seqirus has public health protection at its core. This reflects the promise of our parent company CSL, founded in 1918 to save lives and protect the health of people. Our first true test came with the Spanish Influenza Pandemic and we have been committed to the fight against influenza ever since.&nbsp;
As the only vaccine company with a singular global focus on influenza, Seqirus has pioneered new innovative technologies including cell-based vaccines and adjuvants to help protect against influenza. Seqirus Canada has been a trusted and reliable partner to the Canadian Government since 2010, protecting communities from both seasonal influenza and influenza pandemic threats, by providing FLUAD&reg;, AFLURIA&reg; TETRA, FLUCELVAX&reg; QUAD and FOCLIVIA&reg; to Canadians.&nbsp;
&reg; Registered trademarks of Seqirus UK Limited or its affiliates
&nbsp;

Seqirus

About Pfizer&nbsp;
Pfizer Canada ULC is the Canadian operation of Pfizer Inc., one of the world's leading biopharmaceutical companies. Our diversified health care portfolio includes some of the world&rsquo;s best known and most prescribed medicines and vaccines. Pfizer Inc. invested US$ 8.65 billion in 2019 globally toward developing safe and effective medicines. To learn more about Pfizer Canada, visit pfizer.ca or you can follow us on LinkedIn, Facebook, Twitter or YouTube.&nbsp;
<a href="https://www.pfizer.ca/contact-us" target="_blank" rel="noopener">Contact Us | Pfizer Canada</a>
&Agrave; propos de Pfizer&nbsp;
Pfizer Canada SRI est la filiale canadienne de Pfizer Inc., l&rsquo;une des principales entreprises biopharmaceutiques &agrave; l&rsquo;&eacute;chelle mondiale. Notre gamme diversifi&eacute;e de produits de soins de sant&eacute; comprend des m&eacute;dicaments et des vaccins figurant parmi les plus connus et les plus prescrits dans le monde. En 2019, Pfizer Inc. a investi 8,65 milliards de dollars am&eacute;ricains &agrave; l&rsquo;&eacute;chelle mondiale dans la mise au point de m&eacute;dicaments s&ucirc;rs et efficaces. Pour en savoir plus sur Pfizer Canada, visitez le site pfizer.ca ou suivez-nous sur LinkedIn, Facebook, Twitter ou Youtube.
<a href="https://www.pfizer.ca/fr/nous-joindre" target="_blank" rel="noopener">Nous joindre | Pfizer Canada</a>

Pfizer Canada Inc

<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta http-equiv="Content-Style-Type" content="text/css">
<title></title>
<meta name="Generator" content="Cocoa HTML Writer">
<style type="text/css">
p.p1 {margin: 0.0px 0.0px 12.0px 0.0px; font: 12.0px 'Circular Std'; color: #353535; -webkit-text-stroke: #353535}
span.s1 {font-family: 'CircularStd-Book'; font-weight: normal; font-style: normal; font-size: 12.00px; font-kerning: none}
</style>
</head>
<body>
As the home healthcare division of Praxair Canada Inc., Medigas is singularly committed to helping people live better lives and supporting the medical professionals who make it all possible. For over 50 years, Medigas has been providing physicians and their patients with home oxygen therapy, sleep therapy and home medical equipment. Throughout Canada, our name has become synonymous with quality home healthcare.
The success of the Medigas organization can be credited to the quality of the people we employ, the support of the communities in which we conduct our business operations, the relationships within our affiliated healthcare network, and most importantly, the on-going loyalty of our customers. Our programs and services are developed to meet the ever-changing healthcare needs of Canadians. From delivering life-enhancing home oxygen services to creating a retail environment for sleep therapy for the evolving healthcare consumer, Medigas leads the way.
</body>
</html>

Medigas

TELUS Health Virtual Pharmacy is the convenient way for Canadians to access the pharmaceutical services they need to help them stay healthy. From ongoing support for complex medication regimens to routine refills and private virtual consultations with experienced pharmacists, Virtual Pharmacy combines modern technology with the personal touch of caring professionals.&nbsp;
Members can manage their pharmacy needs on our app and encrypted online platform with voice and video chat support from knowledgeable professionals &ndash; from the privacy and comfort of home.
By offering streamlined access to care, free and fast delivery of medications, and convenient solutions to support medication adherence, Virtual Pharmacy is ideal for people living with chronic conditions. As an optional part of our other virtual healthcare solutions, including TELUS Health MyCare for individuals and TELUS Health Virtual Care for businesses, Virtual Pharmacy supports our commitment to create a healthier future through a connected, accessible and efficient healthcare system for all Canadians.

TELUS Health

At Teva Canada Innovation, we care deeply about the wellbeing of the patients, caregivers, and communities who rely on us. We serve 200 million people every day, from our role as a global leader in generic and brand-name medicines, to the innovative solutions that we create for our healthcare partners - here in Canada, and around the world.

Teva Canada Innovation

The sole reason the foundation exists is to help Canadians improve their lung health.
We&rsquo;re focused on taking on lung cancer, asthma and COPD. We&rsquo;re also hard at work on health promotion through preventing youth smoking and vaping and protecting Canadians from infectious respiratory diseases &ndash; something we&rsquo;ve all seen the importance of with COVID-19.
Unwavering is our dedication to deliver solutions that educate and empower Canadians to breathe better. We will work tirelessly to give patients and their families the programs and support they so urgently need, invest in research and advocate on their behalf.
We know the healthcare system is not nearly nimble enough to address the massive and growing gaps in prevention, diagnosis and treatment for the one-in-five Canadians literally gasping for breath. We are and we can thanks to our generous donors, valued partners and dedicated volunteers.
Together, we are creating a world where everyone can breathe easier. We are deeply grateful for your support and thank you for being a part of this mission.
Learn more at lunghealth.ca.

Lung Health Foundation

Your feedback is extremely important and will help us shape next year&rsquo;s Better Breathing Week. Complete the <a href="https://www.surveymonkey.com/r/QWBMYWJ" target="_blank" rel="noopener">Session Feedback Survey.</a>
&nbsp;
Speaker: Dr. Vivien Brown, MDCM, CCFP, FCFP, NCMP
&nbsp;
Learning Objectives:&nbsp;
<ul>
<li>Review &nbsp;Influenza prevalence and those at highest risk&nbsp;</li>
<li>Describe the characteristics of the influenza virus and how antigenic drift and antigenic shift affect influenza associated morbidity and mortality&nbsp;</li>
<li>Review why influenza vaccination is not as effective as expected&nbsp;</li>
<li>Review the types of influenza vaccines currently available&nbsp;</li>
<li>Compare egg-based and cell-based influenza vaccine production and associated benefits and challenges&nbsp;</li>
<li>Decide how to choose the right vaccine for your patient&nbsp;</li>
</ul>
&nbsp;
(non-accredited session)

Vivien Brown

Navdeep Grewal

Leanne Gibson

Anju Anand

Hayley Wickenheiser

Guri Pannu

Better together: Diverse expertise and industries coming together for one goal – The “ThisIsOurShot” campaign

Your feedback is extremely important and will help us shape next year&rsquo;s Better Breathing Week. Complete the <a href="https://www.research.net/r/integpallcare" target="_blank" rel="noopener">Session Feedback Survey.</a>
&nbsp;
Speaker: Jos&eacute; Pereira, MBChB, CCFPPC, MSc, FCFP, PhD
Professor and Director, Division of Palliative Care, Department of Family Medicine, McMaster University; Scientific Officer, Pallium Canada, Hamilton, ON
&nbsp;
At the end of this session, participants will be able to:&nbsp;
<ul>
<li>Explain the &ldquo;palliative care approach&rdquo;&nbsp;</li>
<li>Integrate a palliative care approach earlier in the care of patients with advanced lung and other serious illnesses, and not wait until the terminal phase</li>
<li>Discuss the evidence that demonstrates the benefits of early palliative care in these patients&nbsp;</li>
</ul>
&nbsp;
CanMEDs Competencies Addressed:
<ul>
<li>Collaborator,&nbsp;</li>
<li>Communicator,&nbsp;</li>
<li>Medical Expert,&nbsp;</li>
<li>Health Advocate,&nbsp;</li>
<li>Professional</li>
</ul>

José Pereira

The Need to Integrate Palliative Care Earlier

Your feedback is extremely important and will help us shape next year&rsquo;s Better Breathing Week. Complete the <a href="https://www.research.net/r/covid19ltcvac" target="_blank" rel="noopener">Session Feedback Survey.</a>
&nbsp;
Part 1: COVID-19 in Long Term Care: Where Policy, Research and Practice Meet
&nbsp;
Speaker: Dawn Bowdish, PDF, PhD
Canada Research Chair in Aging &amp; Immunity; Executive Director of the Firestone Institute of Respiratory Health; Professor, Department of Medicine, McMaster University, Hamilton, ON
&nbsp;
At the end of this session, participants will be able to:&nbsp;
<ul>
<li>Evaluate the efficacy of COVID-19 vaccinations in preventing infections in long-term care</li>
<li>Differentiate between immune responses to vaccination in residents of long-term care and the general population</li>
<li>Identify ways in which studies of immune responses to vaccination can be used to inform policy makers about the timing and need for additional/ booster doses</li>
</ul>
&nbsp;
CanMEDs Competencies Addressed:
<ul>
<li>Collaborator,&nbsp;</li>
<li>Communicator,&nbsp;</li>
<li>Medical Expert,&nbsp;</li>
<li>Health Advocate,&nbsp;</li>
<li>Professional</li>
</ul>
&nbsp;
&nbsp;
Part 2: COVID-19 Vaccine Dosing Intervals: Immunoresponse&nbsp;
&nbsp;
Speaker: Mylinh Duong, MSc, MBBS, FRACP
Associate Professor, Department of Medicine, Division of Respirology, McMaster University; Head of Service, Respirology, Hamilton Health Sciences; Staff Respirologist, Juravinski Hospital; Research member of FIRH and MIRA; Associate Investigator of PHRI, Kingston, ON
&nbsp;
At the end of this session, participants will be able to:&nbsp;
<ul>
<li>Explain why different dosing intervals were used for COVID-19 vaccines</li>
<li>Illustrate how dosing intervals alter antibody responses</li>
<li>Determine how these results impact decisions on third doses</li>
</ul>
&nbsp;
CanMEDs Competencies Addressed:
<ul>
<li>Collaborator,&nbsp;</li>
<li>Communicator,&nbsp;</li>
<li>Medical Expert,&nbsp;</li>
<li>Health Advocate,&nbsp;</li>
<li>Professional</li>
</ul>

Dawn Bowdish

Mylinh Duong

COVID-19 in Long Term Care: Where Policy, Research and Practice Meet & COVID-19 Vaccine Dosing Intervals: Immunoresponse 

Your feedback is extremely important and will help us shape next year&rsquo;s Better Breathing Week. Complete the <a href="https://www.research.net/r/rescasepres" target="_blank" rel="noopener">Session Feedback Survey.</a>
&nbsp;
Speakers: Dr Isaac Martin, Dr Leigh Minuk, Dr Malcolm-Alexander Blagrove, Dr Kirsten Nesset, Dr Mirna Attalla, Dr Alec Campbell.
&nbsp;
Residents representing each centre in Ontario (Toronto, Toronto-pediatric, Kingston, Hamilton, London, Ottawa)
&nbsp;
At the end of this session, participants will be able to:
<ul>
<li>Identify and evaluate difficult clinical diagnoses based on presentations of cases by Respiratory Residents from the major Ontario academic centres</li>
</ul>
&nbsp;
CanMEDS competencies addressed:
<ul>
<li>Medical Expert,&nbsp;</li>
<li>Health Advocate,&nbsp;</li>
<li>Leader,&nbsp;</li>
<li>Professional,&nbsp;</li>
<li>Scholar&nbsp;</li>
</ul>

Leigh Minuk

Alec Campbell

Malcolm Blagrove

Isaac Martin

Kirsten Nesset

Mirna Attalla

Resident Case Presentations 

Your feedback is extremely important and will help us shape next year&rsquo;s Better Breathing Week. Complete the <a href="https://www.research.net/r/infecyir" target="_blank" rel="noopener">Session Feedback Survey.</a>
&nbsp;
Speaker: Margaret Herridge, MSc, MD, FRCPC, MPH
Professor and Senior Scientist, Department of Medicine, University of Toronto; Staff Intensivist/ Respirologist, University Health Network, Toronto, ON
&nbsp;
At the end of this session, participants will be able to:&nbsp;
<ul>
<li>Identify the key concepts and new developments in infectious lung disease research in 2021&nbsp;</li>
<li>Discuss the implication of this &nbsp;research on infectious lung disease treatments</li>
<li>Implement applicable resources to further follow-up and clinical practice&nbsp;</li>
</ul>
&nbsp;
CanMEDs Competencies Addressed:
<ul>
<li>Collaborator,&nbsp;</li>
<li>Medical Expert,&nbsp;</li>
<li>Scholar</li>
</ul>

Margaret Herridge

Year in Review Infectious Respiratory Disease

Your feedback is extremely important and will help us shape next year&rsquo;s Better Breathing Week. Complete the <a href="https://www.research.net/r/tbyir" target="_blank" rel="noopener">Session Feedback Survey.</a>
&nbsp;
Speaker: Richard Long, BSc, MD, FRCPC, FCCP, FCAHS
Director, TB Program Evaluation and Research Unit and Professor, Department of Medicine, and Adjunct Professor, School of Public Health, University of Alberta, Edmonton, AB
&nbsp;
At the end of this session, participants will be able to:&nbsp;
<ul>
<li>Identify the key concepts and new developments in tuberculosis research and treatments in 2021&nbsp;</li>
<li>Discuss the implication of this research on tuberculosis treatments</li>
<li>Implement applicable resources to further follow-up and clinical practice&nbsp;</li>
</ul>
&nbsp;
CanMEDs Competencies Addressed:
<ul>
<li>Collaborator,&nbsp;</li>
<li>Medical Expert,&nbsp;</li>
<li>Scholar</li>
</ul>

Richard Long

Year in Review Tuberculosis 

Your feedback is extremely important and will help us shape next year&rsquo;s Better Breathing Week. Complete the<a href="https://www.surveymonkey.com/r/QSWXNDG" target="_blank" rel="noopener"> Session Feedback Survey.</a>
&nbsp;
Speaker: Mohammed Hashim&nbsp;
&nbsp;
Speaker: Angela Lee
&nbsp;
Learning objectives:
<ul>
<li>Increase contextual understanding of racialized communities in Canada and the impacts on health access, vaccine confidence, and vaccine uptake</li>
<li>Gain an understanding of recent polling on the state of race relations in Canada</li>
</ul>
&nbsp;
(non-accredited session)

Mohammed Hashim

Angela Lee

Andrew McIvor

Helen Neighbour

Marla Beauchamp

Fireside Chat with Firestone Institute for Respiratory Health: Addressing questions from healthcare professionals and the public with respect to all things COVID-19

Your feedback is extremely important and will help us shape next year&rsquo;s Better Breathing Week. Complete the <a href="https://www.research.net/r/vacconfid" target="_blank" rel="noopener">Session Feedback Survey.</a>
&nbsp;
Speaker: Kathryn Birnie, PhD
University of Calgary, Alberta Children&rsquo;s Hospital&nbsp;
&nbsp;
At the end of this session, participants will be able to:&nbsp;
<ul>
<li>Discuss the extent to which vaccine-related pain and needle fears contributes to vaccine hesitancy for children and adults</li>
<li>List evidence-based pharmacological, psychological, physical, process, and procedural strategies for managing vaccination pain and needle fears for children and adults</li>
<li>Identify evidence-based tools for managing vaccine-related pain and needle fears for children and parents, adults, immunizers/healthcare professionals, and decision-makers</li>
</ul>
&nbsp;
CanMEDs Competencies Addressed:
<ul>
<li>Collaborator,&nbsp;</li>
<li>Communicator,&nbsp;</li>
<li>Medical Expert,&nbsp;</li>
<li>Scholar</li>
</ul>

Learning Agenda

Speakers83 Speakers

Kenneth Wu

Joshua Wald

Jane Philpott

Karen Marshall

Noah Ivers

Laura Desveaux

Andrew McIvor

Juan Pablo De Torres Tajes

Anthony D'Urzo

Ruobing Yang

Aaron St-Laurent

Smita Pakhale

Don Bukstein

Erika Nicholson

Ambreen Sayani

Chanel Kwok

Andrew Robinson

Anand Swaminath

John Dickie

Geneviève Digby

CM Parker

Andrea Fung

Daniel Breadner

Robert Schwartz

Gary Rodin

Brandon Sheffield

Michael Chaiton

Laurie Zawertailo

Rosa Dragonetti

Paul Wheatley-Price

Trisha Tulloch

Peter Selby

Anju Anand

Navdeep Grewal

Leanne Gibson

Guri Pannu

José Pereira

Dawn Bowdish

Mylinh Duong

Margaret Herridge

Richard Long

Kathryn Birnie

Jody Hamilton

Tim Monds

Diane Colton

Jennifer Roy

MaryAnn Bradley

Onai Muvezwa

Wendy Reid

Lena Faust

Isaac Martin

Malcolm Blagrove

Leigh Minuk

Kirsten Nesset

Mirna Attalla

Alec Campbell

Howard Song

Brian Conway

Natasha Sabur

Carrie Dain

Alexandre Menard

Hayley Wickenheiser

Jody Hamilton

Imran Satia

Baileigh Sornberger

Stephanie Snow

Christian Finley

Christopher Davis

Meyer Balter

Charles Chan

Neil Maharaj

Delanya Podgers

Carmela Graziani

Alan Kaplan

Vivien Brown

Mohammed Hashim

George Habib

Barbara Melosky